tiprankstipranks
Trending News
More News >
RepliCel Life Sciences Inc (REPCF)
OTHER OTC:REPCF
US Market

RepliCel Life Sciences (REPCF) Income Statement

Compare
22 Followers

RepliCel Life Sciences Income Statement

Last quarter (Q3 2025), RepliCel Life Sciences's total revenue was C$0.00, a decrease of -100.00% from the same quarter last year. In Q3, RepliCel Life Sciences's net income was C$-18.02K. See RepliCel Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 353.74KC$ 353.74KC$ 353.74KC$ 353.74KC$ 353.74K
Gross Profit
C$ 353.74KC$ 352.26KC$ 353.74KC$ 353.74KC$ 353.74K
Operating Expenses
C$ 713.82KC$ 1.74MC$ 1.75MC$ 2.65MC$ 1.68M
Depreciation and Amortization
C$ 541.00C$ 1.47KC$ 839.00C$ 1.15KC$ 1.57K
EBITDA
C$ -359.46KC$ -1.39MC$ -736.00KC$ -4.07MC$ -1.58M
Operating Income
C$ -360.00KC$ -1.39MC$ -1.39MC$ -2.30MC$ -1.33M
Other Income/Expenses
C$ 262.80KC$ 1.07MC$ 649.47KC$ -1.77MC$ -252.02K
Pretax Income
C$ -97.29KC$ -312.00KC$ -743.00KC$ -4.07MC$ -1.58M
Net Income
C$ -97.29KC$ -312.00KC$ -743.00KC$ -4.07MC$ -1.58M
Per Share Metrics
Basic EPS
C$ 0.00C$ -0.01C$ -0.02C$ -0.13C$ -0.06
Diluted EPS
C$ 0.00C$ -0.01C$ -0.02C$ -0.13C$ -0.06
Weighted Average Shares Outstanding
62.29M 59.24M 37.77M 32.49M 26.96M
Weighted Average Shares Outstanding (Diluted)
62.25M 59.24M 37.77M 32.49M 26.96M
Currency in CAD

RepliCel Life Sciences Earnings and Revenue History